Cart
sales@molnova.com
Pristinamycin IA
CAS No. 3131-03-1
Pristinamycin IA( Mikamycin B | Mikamycin IA )
Catalog No. M26393 CAS No. 3131-03-1
Pristinamycin IA is a substrate for the P-glycoprotein and a cyclo-peptidic macrolactone antibiotic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 231 | In Stock |
|
| 10MG | 375 | In Stock |
|
| 25MG | 627 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePristinamycin IA
-
NoteResearch use only, not for human use.
-
Brief DescriptionPristinamycin IA is a substrate for the P-glycoprotein and a cyclo-peptidic macrolactone antibiotic.
-
DescriptionPristinamycin IA is a substrate for the P-glycoprotein and a cyclo-peptidic macrolactone antibiotic.
-
In Vitro——
-
In Vivo——
-
SynonymsMikamycin B | Mikamycin IA
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3131-03-1
-
Formula Weight866.973
-
Molecular FormulaC45H54N8O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (38.44 mM)
-
SMILESCCC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(NC(=O)C2CC(=O)CCN2C(=O)C(Cc2ccc(cc2)N(C)C)N(C)C(=O)C2CCCN2C1=O)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li Y, Huang C, Fu W, Zhang H, Lao Y, Zhou H, Tan H, Xu H. Screening of the active fractions from the Coreopsis tinctoria Nutt. Flower on diabetic endothelial protection and determination of the underlying mechanism. J Ethnopharmacol. 2020 May 10;253:112645.
molnova catalog
related products
-
N-Acetyl-D-galactosa...
Acetylgalactosamine is an important constituent of brain heteropolysaccharides (glycoproteins).
-
Methyl ganoderate D
The fruit body of Ganoderma lucidum.
-
IDR-1
IDR-1 is an antimicrobial peptide that is active against Gram-positive and Gram-negative bacteria. IDR-1 counters infection by selective modulation of innate immunity without obvious toxicities. IDR-1 has anti-inflammatory and anti-infective properties, enhances the levels of monocyte chemokines, and attenuates pro-inflammatory cytokine release.
